CDKN2A and neoplasm: Interestingly, p19ARF loss alone enabled rapid EMT-driven tumor escape, while p16INK4a deficiency failed to accelerate relapse, indicating that deregulated ARF/p53 signaling may foster breast cancer relapse regardless of Wnt pathway activation [93].